Theravance Biopharma (TBPH) Inventory (2013 - 2018)

Theravance Biopharma (TBPH) has 6 years of Inventory data on file, last reported at $17.9 million in Q3 2018.

• Quarterly Inventory rose 17.47% year-over-year to $17.9 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $17.9 million (up 17.47% YoY) and the FY2017 annual result came in at $16.8 million, up 37.73% from the prior year.
• Inventory was little changed at $17.9 million in Q3 2018 per TBPH's latest filing, from $17.9 million in the prior quarter.
• Across five years, Inventory topped out at $17.9 million in Q3 2018 and bottomed at $9.4 million in Q1 2016.
• The 5-year median for Inventory is $12.5 million (2014), against an average of $13.4 million.
• The widest annual swing landed in 2016, when Inventory slipped 23.76%; it then soared 47.67% in 2018.
• Tracing TBPH's Inventory over 5 years: stood at $12.5 million in 2014, then retreated by 20.25% to $10.0 million in 2015, then increased by 22.14% to $12.2 million in 2016, then soared by 37.73% to $16.8 million in 2017, then grew by 6.49% to $17.9 million in 2018.
• Per Business Quant, the three latest TBPH Inventory figures stand at $17.9 million (Q3 2018), $17.9 million (Q2 2018), and $17.2 million (Q1 2018).

Peer Comparison